Becker's Healthcare September 7, 2023
Type 2 diabetes patients who take a GLP-1 such as Ozempic or Wegovy are associated with higher usage of continuous glucose monitors, Dexcom said Sept. 5, according to an Investor’s Business Daily report.
CGMs are wearables that help measure blood sugar and can be used with insulin pumps. Dexcom, a CGM manufacturer based in San Diego, said it analyzed...